The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women

Endokrynologia Polska

Volumn 59, Issue 1, 2008, Pages 18-22

  Zahorska Markiewicz, Barbara ^a   Olszanecka Glinianowicz, Magdalena ^a   Janowska, Joanna ^a   Kocełak, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

FAS; Obesity; sTNFRs; TNF

Indexed keywords

CHOLESTEROL; FAS ANTIGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; OBESITY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANTIGENS, CD95; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; DIET, REDUCING; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; NITRIC OXIDE; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 42249085593     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hotamisgli GS, Arner P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
2. Hotamisgli GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 1994; 94: 1543-1549.
3. Kern PA, Saghizadeh M, Ong JM et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
4. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role of obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev 1996; 7: 161-173.
5. Diez-Ruiz A, Tilz GP, Zangerle R et al. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Hematol 1995; 54: 1-8.
6. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
7. Watanabe-Fukunaga R, Brannan CI, Iton N et al. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1279.
8. Biancone L, Martino AD, Orlandi V et al. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J Exp Med 1997; 186: 147-152.
9. Krammer PH. CD95(APO-1 Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71: 163-210.
10. Famularo G, Nucera E, Marcellini S et al. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation, and transplantation. Med Hypotheses 1999; 53: 50-62.
11. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 5091: 87-91.
12. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
13. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 2000; 24: 1392-1395.
14. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J et al. Serum concentrations of nitric oxide, TNF-α and TNF soluble receptors in women with overweight and obesity. Metabolism 2004; 53: 1268-1273.
15. Mohamed-Ali V, Goodrick S, Buhner K et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol Endocrinol Metab 1999; 82: 971-975.
16. Hauner H, Bender M, Haastert B et al. Plasma concentrations of soluble TNF-α receptors in obese subjects. Int J Obes 1998; 22: 1239-1243.
17. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J. The effect of weight loss on serum concentrations of NO, TNF-α and sTNFRs. Pol J Endocrinol 2006; 57: 487-193.
18. Thomas LR, Johnson RL, Reed JC et al. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing Hgand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation. J Biol Chem 2004; 50: 52479-52486.